Press Releases

Press Releases

Press Releases

Dec 15, 2020
BALA CYNWYD, Pa. , Dec. 15, 2020 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today announced that it has been selected for addition to the NASDAQ Biotechnology Index
Displaying 1 - 10 of 22